Definitive Contract 75N91019C00040
Award Date
9/9/19
Potential Completion Date
9/8/23
Potential Value
$2M
Federal Agency
National Cancer Institute
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Baltimore, MD 21231, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Radiopharmaceutical Imaging and Dosimetry, LLC, doing business as Radiopharmaceutical Imaging & Dosimetry LLC, a small business. The contract, valued at $299,275, is for a Small Business Innovation Research (SBIR) Phase I project to optimize targeted radionuclide therapy for metastatic liver cancer patients. This contract supports the NCI's broader...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a Small Business Innovation Research (SBIR) Phase I contract to Radiopharmaceutical Imaging And Dosimetry, LLC (doing business as Radiopharmaceutical Imaging & Dosimetry LLC), a for-profit limited liability company. The $299,466.00 firm-fixed-price contract, which was set aside for small businesses, is for the development of user-friendly, platform-independent software to incorporate...
This is a $2,372,276.00 firm fixed price contract awarded by the National Cancer Institute (NCI), a civilian agency, to Doseoptics LLC, a for-profit limited liability company. The contract is for Phase I of a Fast Track Small Business Innovation Research (SBIR) project under Topic 461 to develop a "Conformable Scintillator Array for In Vivo Dosimetry During Radiation Therapy (RT)." The award has a period of performance through September 15, 2027. Doseoptics has previously received over...
This is a firm fixed price contract awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Radiasoft LLC, a small business, for the development of intelligent software for radiation therapy planning. The contract has a potential value of $355,000.00 and a completion date of November 30, 2020. Radiasoft LLC is a limited liability company that specializes in scientific computing for particle beams and X-rays, and has previously supported...
<p>This is a definitive contract awarded by the National Cancer Institute (NCI), a civilian agency, to Radiation Management Associates, LLC, a small business. The contract is for other functions radiation support and related services, with a period of performance ending on December 31, 2007. The contract has a ceiling value of $145,441,264.00 and utilizes a cost-plus-fixed-fee pricing type. The place of performance is Greenbelt, MD. This contract is a set-aside for small businesses.</p>
This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the National Cancer Institute (NCI), part of the Department of Health and Human Services' National Institutes of Health, to Radiomedix, Inc., a small disadvantaged business. The contract, valued at $1,994,002.00, is for the development of targeted radionuclide therapy using 212Pb-octreotate analogs for the treatment of neuroendocrine tumors. The contract was awarded on September 18, 2018 and has a completion date of...
This is a $11,447.57 firm fixed price purchase order contract awarded to Revvity Health Sciences, Inc. (a subsidiary of Revvity Inc.) by the National Cancer Institute, a civilian agency under the Department of Health and Human Services. The contract is for the delivery of unspecified "radioactive" items, with a period of performance ending on January 3, 2025. No set-aside designation was utilized. Revvity Health Sciences is a manufacturer of medical imaging products and provider of...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute (NCI) awarded a $295,650.00 firm fixed-price purchase order to RaySearch Americas Inc., the original developer and distributor of the RayStation treatment planning system software. The software is used for radiation oncology treatment planning and research at the NCI. The contract is for ongoing maintenance services for the government-licensed RayStation software, which is critical...
This contract was awarded by the National Cancer Institute, a civilian agency, to Radiomedix, Inc., a small disadvantaged business, for the Targeted Radionuclide Therapy of Neuroendocrine Tumors Using Pb212-Octreotate Analogs project. The contract has a ceiling value of $298,132.00 and was awarded under the Small Business Innovation Research (SBIR) Program Phase I. The contract is a Definitive Contract with a Firm Fixed Price pricing type and has an ultimate completion date of August 18, 2017.
This is a $80,500.00 firm-fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The contract is not set aside for small businesses. The contract provides for the delivery of specialized radiopharmaceuticals, including Lutetium Lu 177 Dotatate, Lutetium Lu 177 Vipivotide Tetraxetan, and Gallium Ga 68...